PRESS RELEASE published on 07/01/2026 at 14:40, 3 months 9 days ago Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares Abivax prices highly oversubscribed $800M public offering of American Depositary Shares, with increased gross proceeds expected to support commercialization efforts and clinical development Abivax Clinical Development Commercialization Public Offering American Depositary Shares
BRIEF published on 07/01/2026 at 07:35, 3 months 10 days ago Temporary suspension of Abivax shares on Euronext Paris Euronext Paris Biotechnology Abivax American Depositary Shares Temporary Suspension
BRIEF published on 07/01/2026 at 07:35, 3 months 10 days ago Abivax Announces Temporary Suspension of Share Trading on Euronext Paris Euronext Paris Biotechnology Abivax Trading Halt Public Offering
PRESS RELEASE published on 07/01/2026 at 07:30, 3 months 10 days ago Abivax announces temporary trading halt of its ordinary shares on Euronext Paris Abivax announces temporary trading halt of its ordinary shares on Euronext Paris in relation to a public offering for its American Depositary Shares. Trading expected to resume today Euronext Paris Trading Abivax Public Offering Temporary Halt
BRIEF published on 06/30/2026 at 22:53, 3 months 10 days ago Abivax Initiates Public Offering of American Depositary Shares Biotechnology Abivax Public Offering Inflammatory Diseases American Depositary Shares
BRIEF published on 06/30/2026 at 22:51, 3 months 10 days ago Abivax launches a public offering of American Depositary Shares Biotechnology Abivax Obefazimod Nasdaq Ads
BRIEF published on 06/30/2026 at 22:50, 3 months 10 days ago Abivax launches a public offering of American Depositary Shares Biotechnology Abivax Nasdaq Public Offering American Depositary Shares
PRESS RELEASE published on 06/30/2026 at 22:48, 3 months 10 days ago Abivax Announces Launch of Public Offering of American Depositary Shares Abivax announces launch of public offering of American Depositary Shares for approximately $600 million to fund commercialization efforts and research expenses. Underwriters include Leerink Partners and Morgan Stanley Funding Abivax Underwriters Public Offering American Depositary Shares
BRIEF published on 06/29/2026 at 22:52, 3 months 11 days ago ABIVAX: Promising results from the ABTECT trial for ulcerative colitis Security Abivax Obefazimod Ulcerative Colitis Clinical Trial
BRIEF published on 06/29/2026 at 22:10, 3 months 11 days ago ABIVAX: Positive results for obefazimod in refractory ulcerative colitis Security Abivax Obefazimod Clinical Trial Refractory Ulcerative Colitis
Published on 10/10/2026 at 04:45, 1 day 7 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 1 day 10 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 1 day 10 hours ago Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 1 day 13 hours ago Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/09/2026 at 22:15, 1 day 14 hours ago Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call
Published on 10/10/2026 at 16:35, 19 hours 56 minutes ago New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
Published on 10/10/2026 at 16:30, 20 hours 1 minute ago ZPMC-Built Infrastructure Supports China's First Offshore Wind Project to Deploy 18 MW Turbines at Scale
Published on 10/10/2026 at 10:05, 1 day 2 hours ago ONLYOFFICE 10.0 brings AI tools, modular apps, and stronger security to its open-source office suite
Published on 10/09/2026 at 21:24, 1 day 15 hours ago Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Published on 10/09/2026 at 21:17, 1 day 15 hours ago EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected
Published on 10/09/2026 at 19:27, 1 day 17 hours ago Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/08/2026 at 18:30, 2 days 18 hours ago Cegedim: Release of its 2026 Interim Financial Report
Published on 10/08/2026 at 18:00, 2 days 18 hours ago Launch of LINK, the next generation of THIN: Clinityx’s first European Health Data Warehouse, approved by the French Data Protection Authority for 10 years
Published on 10/08/2026 at 17:45, 2 days 18 hours ago Carrefour announces a real estate sale and leaseback transaction involving 35 stores in France and Spain